![Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports](https://www.embopress.org/cms/asset/43890f5e-2f3e-4f45-bf71-d3cbbedc167d/embr202153865-fig-0001ev-m.jpg)
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
![Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials](https://pubs.acs.org/cms/10.1021/acsabm.2c00123/asset/images/large/mt2c00123_0016.jpeg)
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials
![SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-21609-2/MediaObjects/41467_2021_21609_Fig1_HTML.png)
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications
![Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2 - eBioMedicine Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2 - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/a028ed35-e751-472a-9e7e-cd88852475ff/gr1.jpg)
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2 - eBioMedicine
![A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-25331-x/MediaObjects/41467_2021_25331_Fig1_HTML.png)
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications
![Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c798169c-fd55-43b9-94a2-092367281558/gr1_lrg.jpg)
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
![Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-24963-3/MediaObjects/41467_2021_24963_Fig1_HTML.png)
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications
![Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review - K - 2022 - Journal of Medical Virology - Wiley Online Library Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review - K - 2022 - Journal of Medical Virology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/116225ba-b751-441e-91d2-c07548a9b0c6/jmv.v94.10.cover.jpg?trick=1662949293971)
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review - K - 2022 - Journal of Medical Virology - Wiley Online Library
![PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3550aa8c-f5d2-438c-b6a9-f269e7d2878f/cam43331-fig-0001-m.jpg)
PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library
![Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ff3b1786-68d5-4dd4-bc5d-74d2ac3babc4/gr1_lrg.jpg)
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe
![Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy](https://www.frontiersin.org/files/Articles/697876/fcimb-11-697876-HTML/image_m/fcimb-11-697876-g001.jpg)
Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
![Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports](https://www.embopress.org/cms/asset/4997687c-d832-405e-80c8-6b4c3682ee8b/embr202153865-fig-0006-m.jpg)
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
![Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials](https://pubs.acs.org/cms/10.1021/acsabm.2c00573/asset/images/large/mt2c00573_0002.jpeg)